The Brighterside of News on MSN2 天
New CAR-T therapy achieved complete remission in 70% of aggressive cancer patients
CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...
Science Daily3 天
New CAR-T cell therapy shows promise for hard-to-treat cancers
Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...
Interesting Engineering on MSN4 天
US researchers develop next-gen CAR-T therapy to kill hard-to-treat cancers
CART, a next-gen CAR-T therapy for improved targeting and functionality to address this. “ALA-CART improves the ability of ...
News-Medical.Net4 天
New supercharged CAR-T cell therapy shows promise against resistant cancers
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the ...
New CAR-T cell therapy 'ALA-CART' shows promise for hard-to-treat cancers
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...
Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented ...
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...